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Lead Aggravates Viral Disease and
Represses the Antiviral Activity
of Interferon Inducers
by Joseph H. Gainer*
Lead acetate was administered continuously in the drinking water to CD-1 male mice
beginning at 4 weeks of age. An LD,o02o of the lytic viruses or 300 plaque-forming units
of RLV was inoculated intrapertioneally at 6 weeks of age. Lead increased the response
of the mice to all classes of viruses against which it was tested: an RNA picornavirus-
encephalomyocarditis (EMCV), a DNA herpesvirus-pseudoribies, an RNA leukemia-
virus-Rauscher leukemia (RLV), an RNA arbovirus B-St. Louis encephalitis, and an
RNA arbovirus A-western encephalitis. Most studies were performed between lead and
EMCV. Increases in EMCV mortality in lead treated mice over controls ranged from
2X at a lead level of 0.004M to 7 x (100% mortality) at a 0.1M lead level. Splenomegaly
with spleens 800 to 1100 mg in weight containing high titers of RLV occurred in lead
(0.03M)-treated mice 3 and 6 weeks after RLV inoculation; spleens or RLV controls
were normal in weight (200 mg) and were free of virus. Lead did not reduce the pro-
tective effect of mouse interferon (IF) against the lethal action of EMCV, but it did
repress the EMCV antiviral effect of poly I/poly C (PIC) and of Newcastle disease
virus (NDV) against EMCV mortality. These data indicate several new facts concern-
ing adverse effects lead may have on an animal: (1) lead aggravates viral disease,
most likely in part, through reduced IF synthesis; (2) lead represses the anti-EMCV
protective effects of both PIC and of NDV, which, in other reports, were shown to in-
duce IF in radioresistant macrophages (PIC) or in radiosensitive lymphocytes (NDV);
(3) lead may then be said to repress IF induction in two kinds of cells; (4) however,
lead does not inhibit IF action.
Introduction
One of the research programs of the Na-
tional Institute of Environmental Health
Sciences was to screen various classes of
chemicals for their adverse or beneficial ef-
fects on experimental viral infections. Stud-
ies on interactions of this nature appear
warranted for several reasons. (a) A direct
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consideration of this research may lead to
the fact that elevated environmental chemi-
cal levels do in fact aggravate or they may
alleviate viral infections. (b) It is known
that cigarette smoking aggravates influen-
zal infection in man (1), and many chemi-
cals have been shown to increase viral in-
fections experimentally (2). (c) Insofar as
lead poisoning and viral infection is con-
cerned, possible synergism between lead
poisoning and eastern encephalitis viral
(EEV) infection was observed "naturally"
in a dead calf in Florida wherein EEV was
May 1974 113isolated from the brain, the calf had a viral
type of encephalitis histologically, and 20
ppm lead was present in the kidney of the
calf. (J. H. Gainer, unpublished observa-
tions, Fla. Dept. Agriculture, Kissimmee,
Fla, 1964). (d) A viral infection, being a dy-
namic (and not a static) force within a cell
or animal, presents problems diverse from
a strictly classical toxicological sense-the
host must cope with the background chemi-
cal poisoning and then confront itself with
the virus that exerts very powerful forces
on the basic biochemical machinery of the
cell. In contrast, then, to the simple straight-
forward toxicological approach with one
chemical-one host response, here we have
the chemical, the host, and the virus, and
the virus itself exerts many pressures that
just do not exist in the single chemical
toxicological study. In addition the chemical
may influence viral absorption and replica-
tion directly and subsequently may influence
the host's defense mechanisms against the
virus.
Metallic salts represent a diverse group
of naturally occurring biologically active
compounds; and certain toxic metals, as
well as essential metals, perhaps, are being
mobilized by man's activities and therefore
are being increased in the immediate en-
vironment near to man. Lead has been
incriminated as the metal that is being mobi-
lized to the greatest extent by man (3). Metal-
lic salts appeared then to be a logical group
of compounds that should be examined for
their interactions with viral disease.
The intact mouse rather than tissue cul-
tures was chosen as the test host for inter-
actions between metals and viruses for cer-
tain reasons. Although interactions between
metals and viruses most certainly will occur
in tissue cultures, it is almost impossible to
extrapolate tissue culture data to whole
animals and to man because of the many
differences between a highly artificial and;
relatively simple tissue culture system and
the complex whole animal. The animal has
selective absorptive and excretory mecha-
nisms for the chemical that the tissue cul-
ture system most likely lacks. The animal
may concentrate the metal in a specific tis-
sue for which the virus has a special affinity,
cobalt and the encephalomyocarditis virus
(EMCV) both affecting the heart, for ex-
ample (4). This argument may post disad-
vantages to certain studies, however; for
example, cadmium, which concentrates in
the kidney, should ideally be interacted with
a virus that infects the kidney and not one
that infects the heart or brain, as has been
done (5). Certain metals, because of their
lack of adequate solubility in tissue culture
media (lead, for example), present another
barrier to the successful conduct of tissue
culture studies. The mouse is relatively in-
expensive, and it therefore can be used in
sufficient numbers to permit the acquisition
of sufficient data for statistical analysis.
The mouse has been well characterized for
infection studies with several classes of vi-
ruses. It has been argued that tissue cultures
rather than whole animals should be used,
because mechanisms are more easily de-
finable in tissue cultures; this may be the
case,. but data that follow illustrate that
much in terms of mechanisms has been
learned in the intact animal.
This paper describes in mice (a) the in-
teractions between lead treatment and five
different viral infections, (b) interactions
between lead treatment and interferon ac-
tion, and (c) interactions between lead treat-
ment and the antiviral actions of the inter-
feron inducers poly I/poly C and Newcastle
disease virus.
Methods
Metals, Mice, Viruses
A screening program was begun in which
the salts of metals were interacted with a
few viruses in CD-1 male mice (Charles
River Breeding Farms, Wilmington, Mass.).
Metals were administered continuously in
demineralized drinking water, beginning
with mice at 4 weeks of age. A safe con-
centration of a metal was determined as the
maximum concentration of the metal the
mice could tolerate without appreciable re-
duction in liquid consumption or appreciable
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laboratory strains; the viruses were inocu-
lated intraperitoneally (IP) at 6 weeks of
age. Death rate was the parameter used in
the lytic viral infections; splenomegaly was
followed in the Rauscher viral infections.
Lead acetate was found to be the least toxic
of the metallic salts tested; however, lead
was found to result in a large magnitude
of synergism of the viral disease response.
In fact, of several metals tested, NaAsO2,
CdSO4, CoS04, HgCl2, NiSO4, and lead ace-
tate, lead acetate was the most potent "syner-
gizer" of viral infections (4-6).
Interferon Studies
To attempt to delinate modes of action of
the lead-enhanced virus-induced disease, in-
terferon (IF) was considered to be involved
in that IF is one of the first lines of de-
fense an animal has against a viral infec-
tion (7). Virus titers and IF levels were
examined sequentially in brain and spleen
of mice infected with the encephalomyo-
carditis virus (EMCV). Preliminary assays
of the titers of virus and of IF in spleens
and brains of virus-control mice and of lead-
treated EMCV-infected mice killed or dying
2 to 4 days after viral inoculation revealed
high titers of virus and of IF' in tissues from
both groups of mice. Lack of sufficient time
prevented careful study of these two para-
meters to determine if in fact the lead-
treated, virus-infected mice had lower IF
titers and higher virus titers than did the
the nontreated virus-infected control mice.
Nevertheless, lead-treated EMCV infected
mice did contain high titers of EMCV, in-
dicating that these mice were in fact dying
of a virus-induced encephalitis.
Earlier studies had shown that arsenicals
repressed the antiviral activity of the IF
inducer poly I/poly C for EMCV mortality
(8). Poly I/poly C has been shown to pro-
tect mice against EMCV mortality, the me-
chanism of action being through the synthe-
sis and action of IF (9). Recently it was
reported that poly I/poly C induced IF syn-
thesis in large radio-resistant macrophages
whereas Newcastle disease virus (NDV),
which will also induce the synthesis of IF,
induced it in radiosensitive lymphocytes
(10, 11). The effect of lead acetate on the
antiviral activity of poly I/poly C and of
NDV was determined. The method of pro-
cedure was simply that mice were laden with
the lead as in the straight virus procedures.
Poly I/poly C (Biopolymers, Chagrin Falls,
Ohio, lot no. 12) or NDV was administered
IP, and 2 or 24 hr later, respectively, an
LD9. of virus was administered. A commeri-
cal lot of NDV (La Sota strain, Bi type
vaccine, American Scientific Laboratories,
Madison, WI) was used. Deaths were tal-
lied and differences were compared. The in-
terferon inducers protected against EMCV
mortality whereas the lead-treated mice were
not protected by either IF inducer from
dying with EMCV infection. Lead was then
given at various times with regard to the
poly I/poly C to determine certain time se-
quences of lead repression of IF synthesis.
Lead was also tested against preformed
mouse interferon in vitro and in vivo to
determine if it would influence the antiviral
activity of the interferon.
Results
Lead and Viral Disease
Table 1 shows that lead acetate exagger-
ated the response of mice to all viruses
against which it was tested. Although the
differences between virus controls and lead
treated were not statistically significant in
the case of the St. Louis encephalitis and
the western encephalitis virus, there was a
higher per cent morality in the lead-treated
mice than there was in the controls in all
cases. The concentration of lead used with
the pseudorabies virus and with the two
encephalitis viruses was not as high as in
the case of EMCV. Spleens in the lead-
treated, Rauscher virus-infected mice were
very large; and high titers of virus were
present in lead-treated Rauscher virus-
infected spleens (up'to 108 PFU/gram); vi-
rus was not recovered from virus-control
spleens.
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in mice.,
No. dead/no. inoculated and per cent mortality
Demineralized Lead
Concentration of water acetate-
Virus lead used, M control mice treated mice P
Encephalomyocarditis 0.01 and 0.004b 0/31, 0% 7/32, 22% <0.05
0.05 6/41, 15% 9/21, 43% 0.04
0.10 6/41, 15% 11/22, 86% <0.01
Pseudorabies 0.0003 b 4/34, 12% 6/15, 40% <0.05
0.003 b 6/34, 12% 4/14, 29% 0.06
St. Louis encephalitis 0.03 b 5/23, 22% 7/20, 35% N.S.
Western encephalitis 0.015 and 0.03b 2/20, 10% 5/39, 13% N.S.
Rauscher leukemia 0.03 204±31, 3WPI; 858± 96, 3WPI 00 142±12, 6WPI; 1048±374, 3WPI <0.01
Mice were treated with lead acetate beginning at 4 weeks of age; at 6 weeks they were infected with
viruses. Mortality patterns were followed in the first 4 viruses; spleen sizes and splenic virus content were
observed in the Rauscher leukemia infections.
b Unpublished findings; other data from Gainer (5, 1 6).
e Spleen weights in mg with standard deviations; WPI denotes weeks after virus inoculation.
Table 2. Effect of lead acetate on the antiviral activ-
ity of poly I/poly C and on Newcastle disease virus
on EMCV mortality.,
Virus mortality
Demineralized
Lead water
Interferon inducer acetate controls P
Poly I/poly C 12/19, 63% b 1/20, 5% 0.001
Newcastle disease
virus (NDV) 10/15, 67% * 20/74, 27% 0.008
' Lead acetate was begun at 4 weeks of age. At 6
weeks poly I/poly C and NDV were given IP, fol-
lowed 2 and 24 hr later, respectively, with virus.
Data are from Gainer (12).
b Lead acetate, 0.03M.
° Lead acetate, 0.003M.
Lead and Interferon Inducers
The interactions of lead acetate with poly
I/poly C and with NDV in their antiviral
protective activities against EMCV morta-
lity are presented in Table 2. The lead level
in the poly I/poly C study was tenfold
that in the NDV study, and the poly I/poly
C alone protected against EMCV mortality
to a greater magnitude than did the NDV,
it is not possible to make direct comparisons
between lead and poly I/poly C and lead
and NDV. Chessboard experiments to work
out these interactions in intricate detail
were not performed.
Three concentrations of lead acetate, 0.003,
0.01, and 0.03M, were interacted with 0.2
mg/kg of poly I/poly *C. The 0.03M lead
exerted as high a reversal activity against
poly I/poly C, 9/10, P = 0.01, as did the ten-
fold concentration of lead, 0.03M, 7/9, P =
0.05; poly I/poly C control mortality was
5/17, 29%. The intermediate lead concentra-
tion of 0.O1M resulted in a mortality of
7/10, P = 0.07 (12).
Temporal Relationships of
Lead and Poly I/Poly C
Table 3 presents the results of temporal
relationships between the administration of
lead acetate and poly I/poly C. Lead given
Table 3. Influence of the time of administration of
lead on the antiviral activity of poly I/poly C in
mice.'
Lead treatment Mortality P
1 hr before poly I/poly C 11/20, 55%o NS
4 hr after poly I/poly C 5/16, 31% 0.05
24 hr after poly I/poly C 3/20, 15% 0.01
Virus controls, no lead,
no poly I/poly C 27/41, 66o -
'Six-week-old mice were used. Lead acetate, 100
mg/kg, was given IP at times before and after Poly
I/Poly C, 0.3 mg/kg, IP. EMCV was given IP 1 hr
after poly I/poly C. Data are from Gainer (12).
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of poly I/poly C's antiviral activity. When
given 4 hr after poly I/poly C, lead still
reversed the protective effect to some ex-
tent; but 24 hr after poly I/poly C, lead did
not have any influence.
Effect of Lead on Interferon Action
Mouse interferon was prepared by inject-
ing poly I/poly C, 7.5 mg/kg, IP into 8 week
old C3H male mice (Jackson Labs., Bar Har-
bor, Maine). The animals were exsangui-
nated 4-5 hr later. Plasma from heparinized
blood was pooled with triturated spleens
and lungs, this mixture comprised the IF
preparation. Plasmas, spleens, and lungs
were collected from normal untreated mice
and served as control preparations. Lead
acetate when administered prior to the ad-
ministration of IF did not influence the
protective activity of the interferon (Table
4). This lack of effect of the lead on IF ac-
tion compares favorably with in vitro studies
in which lead at 10- and 10-5 M, when added
to IF preparations, did not inhibit the an-
tiviral activity of IF against the vesicular
stomatitis virus (12). In the in vitro studies
the difficulty was encountered that lead is
quite insoluble in tissue culture mediums;
it is conjectured that, because of insolu-
bility of the lead acetate in tissue cultures,
it was probably not possible to achieve suf-
ficiently high concentrations to test ade-
Table 4. Effect of lead acetate on the antiviral activ-
ity of interferon against encephalomyocarditis
virus mortality in mice.'
Treatment Mortality,
no. dead/
0 hr 2 hr 4 hr total P
Lead acetate, Interferon Virus 11/20 0.01
100 mg/kg
Saline Interferon Virus 11/20 0.01
Saline Normal Virus 20/21
mouse
tissues
(controls)
'Five-week-old mice were injected three times each
IP as stated. Mortality was followed. Data are from
Gainer (12).
quately the effects of lead on interferon
action.
Discussion
Data presented show that lead poisoning
aggravated the response of mice to the five
viruses against which it was tested. Four
viruses are of the RNA type, and one, the
pseudorabies, is a DNA virus. The concen-
trations of lead used were not the same
with every virus, so that one is uncertain
that the magnitude of virus stimulation
from virus to virus is really comparable. In
addition, the dose of virus used is hardly
comparable from one virus to the next, the
number of virus particles per infectious unit
being of considerable consequence as to
whether or not a virus disease process may
be exaggerated by a chemical poisoning.
Nonetheless, responses to all viruses in the
mice were exaggerated by the lead treat-
ment, although not significantly so in the
case of the two encephalitis viruses. It is
possible that the lead had not reached strong
virus-enhancing levels in the brains, where
it would most likely have significant effect
with the encephalitis viruses. It is suggested
that the lead is attacking a common bio-
chemical parameter in the infectious process
(such as interferon), rather than a specific
biochemical pathway related to one partic-
ular virus only. Although the determina-
tions of virus titers and IF levels were not
satisfactory and did not delineate particular
relationships between the two entities, other
interrelationships between lead poisoning
and IF formation and action did lead to
very significant results. Lead poisoning did
not inhibit interferon action either in vitro
or in vivo. This finding would suggest that
for IF to be active another protein is not
formed to account for the antiviral action;
this contrasts with earlier findings in which
it is reported that IF results in synthesis
of a secondary protein that actually pro-
vides for the antiviral action (7). In the
case of lead poisoning, the interferon is
fully active in its presence; this suggests
that if the lead inhibits RNA synthesis,
as has been reported (13), it is not in-
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ing as a primary effect of interferon action.
Lead poisoning inhibited the anti-EMCV
protective effect of poly I/poly C, presum-
ably in large macrophages, and of Newcastle
disease virus, presumably in small lympho-
cytes. These findings suggest strongly but do
not confirm unequivocally that the mechanism
of lead enhancement of viral disease is
through depressed interferon synthesis. Since
the lymphocytes are radiosensitive, one
might predict that lead poisoning would add
or would synergize with radiation-induced
injury to further intensify viral disease re-
sponses.
Interactions of lead poisoning with Raus-
cher virus infection affords other points of
discussion in addition to probable effects of
lead poisoning on the defense mechanisms.
Lead poisoning causes a myriad of patho-
logical effects, one of the most noteable of
which is the induction of anemia (14)
through an inhibition of 8-aminolevulinic
acid dehydratase and heme synthetase which
are critical for hemoglobin synthesis. Ebert
et al. (15) illustrated recently that in RLV
infection, reduced 8-aminolevulinic acid syn-
thetase activity was associated with the de-
velopment of anemia and splenomegaly. Thus
Rauscher virus infection and lead poisoning
may be acting synergistically through in-
hibition of similar enzymes involved in hemo-
globin synthesis.
Sequential studies on the plasmas and
tissues in the lead-poisoned animals after
virus infection for such parameters as anti-
body, leukocyte counts, interferon, and virus
titers would clarify several issues concern-
ing mechanisms involved in these interac-
tions. The temporal relationships found here
between lead and poly I/poly C indicates
clearly that lead disrupts interferon synthe-
sis and not interferon action.
Summary
The administration of lead acetate in the
drinking water aggravated the response of
mice to five viruses against which it was
tested: encephalomyocarditis (EMCV), pseu-
dorabies, Rauscher leukemia, St. Louis ence-
phalitis, and western encephalitis. On treat-
ment with 0.lM lead, EMCV mortality
increased sevenfold (to 100%o mortality)
and spleens of mice treated with 0.03M lead
and infected with the Rauscher leukemia
virus weighed 800-1100 mg and contained
nearly 10 8 PFU of virus per gram 3 and 6
weeks after virus inoculation; Rauscher
virus-infected control spleens were normal
in weight and did not contain any virus.
Lead did not inhibit interferon (IF) ac-
tion in mouse embryo cultures in its inhibi-
tion of plaque formation by the vesicular
stomatitis virus, and it did not inhibit IF
action in that it did not reduce the anti-
EMCV protective effect of IF against EM-
CV mortality in the intact mouse. However
lead did repress the EMCV antiviral effect
of poly I/poly C (PIC) and of Newcastle
disease virus (NDV) against EMCV mortal-
ity. These data indicate several new facts
concerning adverse effects lead may have
with respect to a viral infection: (1) lead
aggravates viral disease, most likely in part
through reduced IF synthesis, as a result of
reduced RNA synthesis; (2) lead represses
the anti-EMCV protective effects of both
PIC and of NDV, which, in other reports,
were shown to induce IF in radioresistant
macrophages (PIC) and in radiosensitive
lymphocytes (NDV); lead may then be said
to have the capacity to repress IF synthesis
in at least two kinds of cells; (3) however,
lead does not inhibit IF action.
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